Ominous sign for Korean drugmakers

Published: 2009-09-10 07:00:00

Updated: 2009-09-10 07:00:00

Along with the government’s strong will to cut the prices of drugs in question by 20 percent if their producers are found to offer rebates to doctors and pharmacists, domestic companies have again been subject to a difficult situation, according to market experts.

They pointed out that althou...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK